Policy and Legislation
The model ties payment to a patient's conditions and care needs rather than volume of services provided.
Program is a crucial part of operations for hospitals that serve vulnerable populations because it offsets the high costs medications.
More than three quarters of Democrats said they want candidates to talk about universal healthcare "a lot," with economic opportunity coming in second.
Brand drug manufacturers are delaying the development and entry of generics, federal officials say.
Regulatory changes for 2019 could save health plans up to $54 million a year, CMS says.
States with at least 85% of their Medicaid population in managed care could implement nominal payment cuts without ensuring providers will assure access to care.
Specialists say legislation is needed to grow workforce and hold pharmacy benefit managers accountable for driving prices up for consumers.
There's "no perceivable benefit" to patients as the chargemaster "rack rate" is not a reflection of what they'll end up paying, experts say.
Senate committee is taking a closer look at the drug discount program.
Medicaid waivers will not include lifetime limits, says CMS Administrator Seema Verma.